Drugs / Cordstem-ST
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02378974 | Feb 2015 → Apr 2017 | cerebral infarction | CHABiotech CO., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cordstem-ST | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02378974 ↗ |
| Modality | Cell therapy | “Human Umbilical Cord-derived Mesenchymal Stem Cells” NCT02378974 ↗ |
| Route | Intravenous | “After Intravenous Transplantation of Human Umbilical Cord-derived Mesenchymal Stem Cells” NCT02378974 ↗ |